Skip to main content
VulnerabilityPublished

CVE-2025-64778: NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text

Source GCVE Database

0
Compare
Authoritative record:CVE-2025-64778· High 8.4

Not known to be exploited · CVSS 8.4 High.

Data as of 22 Nov 2026, 02:48 UTC

CVSS 4.0 base score
8.4High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (icscert)CVSS 4.08.4
CNA (icscert)CVSS 3.17.3
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Dec 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 21 Nov 2026.

What to do

AI-suggested

Until an official fix is available, restrict access to systems running affected versions to trusted users only and consider additional access controls to limit exposure.

Description

NMIS/BioDose software version 22.02 and earlier contain executable binaries with hard-coded plaintext passwords. These passwords could be used to gain unauthorized access to the application and its database. The vulnerability has a high severity rating with a CVSS score of 7.3.

References

Community reviews

Loading reviews…